Osteoarthritis of Knee Clinical Trial
— PROACTOfficial title:
Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)
This mechanistic clinical trial proposes to test whether a five-day course of mindfulness meditation training (MMT) and tDCS, and their combination, can enhance pain modulatory balance and pain-related brain function, reduce clinical pain, among African Americans and non-Hispanic whites with knee osteoarthritis (OA). This approach will provide evidence that targeting stress and pain-related brain function will reduce OA-related pain and ethnic group differences therein.
Status | Recruiting |
Enrollment | 240 |
Est. completion date | February 28, 2025 |
Est. primary completion date | February 28, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 45 Years to 85 Years |
Eligibility | Inclusion Criteria: - Unilateral or bilateral symptomatic knee OA based on American College of Rheumatology Clinical criteria - Participant reports primary ethnic/race group as either African American or non-Hispanic white Exclusion Criteria: - Actively symptomatic systemic rheumatic disease/condition (e.g. rheumatoid arthritis, systemic lupus erythematosus), or fibromyalgia that results in pain outside the knee that is equal to or worse than the participant's knee pain. - A history of clinically significant surgery to the index knee. - Daily use of opioids. We will exclude patients using opioids daily as both continued use and temporary withdrawal from these medications this could affect pain perception and response to interventions. Other medications being used will be recorded and controlled in statistical analyses as needed. - Use of some centrally acting sodium channel blockers, calcium channel blockers and NMDA receptor antagonists, because some of these medications can block tDCS effects. Other medications can potentially influence response to tDCS (e.g. SSRIs, beta-blockers); therefore, consistent with recent recommendations (2), we will assess use of these medications and include them as covariates in our statistical models. - Uncontrolled hypertension (i.e. SBP/DBP of > 150/95) or unstable or activity limiting cardiovascular or peripheral arterial disease. These exclusions are in place primarily for safety reasons, because the cold pressor task represents a cardiovascular challenge. However, uncontrolled hypertension can also affect pain perception, which is another reason for excluding these individuals. - Neurological disease (e.g. Parkinson's, multiple sclerosis, epilepsy) or evidence of previous brain injury, including stroke and traumatic brain injury. - Serious psychiatric disorder requiring hospitalization within the past 12 months or characterized by active suicidal ideation. - Current substance use disorder or history of hospitalization for treatment of substance use disorder. - Diminished cognitive function that would interfere with understanding of study procedures. |
Country | Name | City | State |
---|---|---|---|
United States | University of Alabama at Birmingham | Birmingham | Alabama |
United States | University of Florida | Gainesville | Florida |
Lead Sponsor | Collaborator |
---|---|
University of Florida | National Institute on Aging (NIA) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). | 26 question index to assess knee OA pain; ranked from 'no pain' to 'extreme pain' | Baseline; Day 1; Day 2; Day 3; Day 4; Day 5 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03274713 -
Efficacy of Electro-acupuncture Versus Manual Acupuncture on Knee Osteoarthritis
|
N/A | |
Completed |
NCT04535596 -
Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03918291 -
Whole-body Vibration Training on Functional Performance of the Elderly With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06263517 -
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
|
Phase 2/Phase 3 | |
Completed |
NCT01453738 -
Allogeneic Mesenchymal Stem Cells in Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT01027819 -
Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT01186211 -
Feasibility of Outpatient Total Knee Arthroplasty
|
||
Active, not recruiting |
NCT00261066 -
Outcome Following Orthopaedic Surgery
|
||
Completed |
NCT03484910 -
Biofeedback With Cycling Exercise in OA Knee Patients
|
N/A | |
Completed |
NCT03492320 -
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
|
||
Completed |
NCT01449552 -
Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT
|
N/A | |
Completed |
NCT06254976 -
Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03428893 -
Mobile Technology to Support Physical Therapy Exercise
|
N/A | |
Completed |
NCT05081921 -
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
|
Phase 1/Phase 2 | |
Completed |
NCT02850068 -
Geniculate Artery Embolization for the Treatment of Knee Pain
|
N/A | |
Active, not recruiting |
NCT03110172 -
Short-term Efficacy of Antidepressant in Patients Underwent TKA
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT02623660 -
Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery
|
N/A | |
Completed |
NCT02579174 -
Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation
|
N/A | |
Completed |
NCT00790985 -
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
|
N/A | |
Recruiting |
NCT02722772 -
Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis
|
N/A |